Last reviewed · How we verify
DEX group: Dexamethasone
DEX group: Dexamethasone is a Small molecule drug developed by The Guthrie Clinic. It is currently FDA-approved. Also known as: Steroid therapy.
At a glance
| Generic name | DEX group: Dexamethasone |
|---|---|
| Also known as | Steroid therapy |
| Sponsor | The Guthrie Clinic |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and Palonosetron (NA)
- Efficacy Comparison of DExamethasone Intravitreal Implant Combined With Aflibercept Versus Aflibercept Monotherapy in Treatment-naïve Inflammatory Diabetic Macular Edema Patients (PHASE4)
- Efficacy of Non-weight Based, Low Dose Dex-Dex Adjuncts in Prolonging Peripheral Nerve Blocks (PHASE1, PHASE2)
- Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma (PHASE2)
- Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions (PHASE3)
- MeDex: No Perioperative Dexamethasone in Brain Metastases (NA)
- Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) (PHASE2, PHASE3)
- Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DEX group: Dexamethasone CI brief — competitive landscape report
- DEX group: Dexamethasone updates RSS · CI watch RSS
- The Guthrie Clinic portfolio CI
Frequently asked questions about DEX group: Dexamethasone
What is DEX group: Dexamethasone?
DEX group: Dexamethasone is a Small molecule drug developed by The Guthrie Clinic.
Who makes DEX group: Dexamethasone?
DEX group: Dexamethasone is developed and marketed by The Guthrie Clinic (see full The Guthrie Clinic pipeline at /company/the-guthrie-clinic).
Is DEX group: Dexamethasone also known as anything else?
DEX group: Dexamethasone is also known as Steroid therapy.
What development phase is DEX group: Dexamethasone in?
DEX group: Dexamethasone is FDA-approved (marketed).
Related
- Manufacturer: The Guthrie Clinic — full pipeline
- Also known as: Steroid therapy
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing